The company reported a 15 percent increase in extremities sales, which represented 82 percent of reported global sales. However, the company’s U.S. sales underperformed in the lower extremities, sports medicine and biologics businesses.
Worldwide company and extremities growth can be attributed to the company’s new Aequalis Ascend shoulder arthroplasty system and the adoption of the Aequalis reverse shoulder arthroplasty system.
Related Articles on Orthopedic Devices:
Alphatec Spine Reports 3Q Revenue Growth to $47.6M, Driven by U.S. Market
European Small Joint Implant Market to Reach $250M by 2016, Driven by Shoulder Implants
K2M Debuts New Cervical Plate System With Blue Ridge Technology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.